
Melissa Jean Perreira
Examiner (ID: 10386, Phone: (571)272-1354 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1065 |
| Issued Applications | 491 |
| Pending Applications | 87 |
| Abandoned Applications | 511 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5808767
[patent_doc_number] => 20060095122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Implantable devices comprising biologically absorbable star polymers and methods for fabricating the same'
[patent_app_type] => utility
[patent_app_number] => 10/978031
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7491
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20060095122.pdf
[firstpage_image] =>[orig_patent_app_number] => 10978031
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/978031 | Implantable devices comprising biologically absorbable star polymers and methods for fabricating the same | Oct 28, 2004 | Abandoned |
Array
(
[id] => 5601733
[patent_doc_number] => 20060292078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Optical imaging of colorectal cancer'
[patent_app_type] => utility
[patent_app_number] => 10/573606
[patent_app_country] => US
[patent_app_date] => 2004-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7264
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20060292078.pdf
[firstpage_image] =>[orig_patent_app_number] => 10573606
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/573606 | Optical imaging of colorectal cancer | Sep 27, 2004 | Abandoned |
Array
(
[id] => 7237803
[patent_doc_number] => 20050080033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Biodegradable polyacetals for in vivo polynucleotide delivery'
[patent_app_type] => utility
[patent_app_number] => 10/946383
[patent_app_country] => US
[patent_app_date] => 2004-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5378
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0080/20050080033.pdf
[firstpage_image] =>[orig_patent_app_number] => 10946383
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/946383 | Biodegradable polyacetals for in vivo polynucleotide delivery | Sep 20, 2004 | Issued |
Array
(
[id] => 7097270
[patent_doc_number] => 20050129728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Sustained release pharmaceutical composition'
[patent_app_type] => utility
[patent_app_number] => 10/943947
[patent_app_country] => US
[patent_app_date] => 2004-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6975
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20050129728.pdf
[firstpage_image] =>[orig_patent_app_number] => 10943947
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/943947 | Sustained release pharmaceutical composition | Sep 19, 2004 | Abandoned |
Array
(
[id] => 6971380
[patent_doc_number] => 20050037090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Combination therapy including a cyclooxygenase-2 inhibitor and an antineoplastic agent'
[patent_app_type] => utility
[patent_app_number] => 10/945422
[patent_app_country] => US
[patent_app_date] => 2004-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31269
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20050037090.pdf
[firstpage_image] =>[orig_patent_app_number] => 10945422
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/945422 | Combination therapy including a cyclooxygenase-2 inhibitor and an antineoplastic agent | Sep 19, 2004 | Abandoned |
Array
(
[id] => 5726311
[patent_doc_number] => 20060057071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Paramagnetic complexes with pendant crown compounds showing improved targeting-specificity as MRI contrast agents'
[patent_app_type] => utility
[patent_app_number] => 10/940832
[patent_app_country] => US
[patent_app_date] => 2004-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 15669
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20060057071.pdf
[firstpage_image] =>[orig_patent_app_number] => 10940832
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/940832 | Paramagnetic complexes with pendant crown compounds showing improved targeting-specificity as MRI contrast agents | Sep 13, 2004 | Abandoned |
Array
(
[id] => 5135567
[patent_doc_number] => 20070077196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-05
[patent_title] => 'Radiolabeled thymidine solid-phase extraction purification method'
[patent_app_type] => utility
[patent_app_number] => 10/570067
[patent_app_country] => US
[patent_app_date] => 2004-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3749
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20070077196.pdf
[firstpage_image] =>[orig_patent_app_number] => 10570067
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/570067 | Radiolabeled thymidine solid-phase extraction purification method | Sep 12, 2004 | Abandoned |
Array
(
[id] => 7208286
[patent_doc_number] => 20050053551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Use of a combination of gadolinium-based contrast media and iodinated contrast media as a contrast agent for X-ray based medical imaging procedures'
[patent_app_type] => utility
[patent_app_number] => 10/936608
[patent_app_country] => US
[patent_app_date] => 2004-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4139
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20050053551.pdf
[firstpage_image] =>[orig_patent_app_number] => 10936608
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/936608 | Use of a combination of gadolinium-based contrast media and iodinated contrast media as a contrast agent for X-ray based medical imaging procedures | Sep 7, 2004 | Abandoned |
Array
(
[id] => 7159400
[patent_doc_number] => 20050084451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Novel chelating agents and chelates and their use'
[patent_app_type] => utility
[patent_app_number] => 10/928143
[patent_app_country] => US
[patent_app_date] => 2004-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10219
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20050084451.pdf
[firstpage_image] =>[orig_patent_app_number] => 10928143
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/928143 | Novel chelating agents and chelates and their use | Aug 29, 2004 | Abandoned |
Array
(
[id] => 5902421
[patent_doc_number] => 20060045846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-02
[patent_title] => 'Reagents and methods for labeling terminal olefins'
[patent_app_type] => utility
[patent_app_number] => 10/929624
[patent_app_country] => US
[patent_app_date] => 2004-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12434
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20060045846.pdf
[firstpage_image] =>[orig_patent_app_number] => 10929624
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/929624 | Reagents and methods for labeling terminal olefins | Aug 29, 2004 | Abandoned |
Array
(
[id] => 7097317
[patent_doc_number] => 20050129775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Ferromagnetic particles and methods'
[patent_app_type] => utility
[patent_app_number] => 10/928452
[patent_app_country] => US
[patent_app_date] => 2004-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11850
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20050129775.pdf
[firstpage_image] =>[orig_patent_app_number] => 10928452
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/928452 | Ferromagnetic particles and methods | Aug 26, 2004 | Issued |
Array
(
[id] => 5023530
[patent_doc_number] => 20070149496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Water-soluble compound'
[patent_app_type] => utility
[patent_app_number] => 10/923615
[patent_app_country] => US
[patent_app_date] => 2004-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 108431
[patent_no_of_claims] => 97
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20070149496.pdf
[firstpage_image] =>[orig_patent_app_number] => 10923615
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/923615 | Water-soluble compound | Aug 19, 2004 | Abandoned |
Array
(
[id] => 7249072
[patent_doc_number] => 20040258620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => '(Ethylene)-( propylene)-triaminepentaacetic acid derivatives, process for their production, and their use for the production of pharmaceutical agents'
[patent_app_type] => new
[patent_app_number] => 10/481272
[patent_app_country] => US
[patent_app_date] => 2004-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 20504
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20040258620.pdf
[firstpage_image] =>[orig_patent_app_number] => 10481272
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/481272 | (Ethylene)-( propylene)-triaminepentaacetic acid derivatives, process for their production, and their use for the production of pharmaceutical agents | Aug 18, 2004 | Abandoned |
Array
(
[id] => 6938501
[patent_doc_number] => 20050112064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'DNA-dependent MRI contrast agents'
[patent_app_type] => utility
[patent_app_number] => 10/916943
[patent_app_country] => US
[patent_app_date] => 2004-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20622
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112064.pdf
[firstpage_image] =>[orig_patent_app_number] => 10916943
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/916943 | DNA-dependent MRI contrast agents | Aug 11, 2004 | Abandoned |
Array
(
[id] => 5687722
[patent_doc_number] => 20060286037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Heart-slowing drug containing short-acting ß blocker as the active ingredient'
[patent_app_type] => utility
[patent_app_number] => 10/567569
[patent_app_country] => US
[patent_app_date] => 2004-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4604
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20060286037.pdf
[firstpage_image] =>[orig_patent_app_number] => 10567569
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/567569 | Heart-slowing drug containing short-acting ß blocker as the active ingredient | Aug 5, 2004 | Abandoned |
Array
(
[id] => 5819916
[patent_doc_number] => 20060024229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Method and product for locating an internal bleeding site'
[patent_app_type] => utility
[patent_app_number] => 10/903303
[patent_app_country] => US
[patent_app_date] => 2004-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2751
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024229.pdf
[firstpage_image] =>[orig_patent_app_number] => 10903303
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/903303 | Method and product for locating an internal bleeding site | Jul 28, 2004 | Abandoned |
Array
(
[id] => 6996223
[patent_doc_number] => 20050136001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Fluorinated carbohydrate conjugates'
[patent_app_type] => utility
[patent_app_number] => 10/901441
[patent_app_country] => US
[patent_app_date] => 2004-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 22683
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20050136001.pdf
[firstpage_image] =>[orig_patent_app_number] => 10901441
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/901441 | Fluorinated carbohydrate conjugates | Jul 28, 2004 | Issued |
Array
(
[id] => 7345869
[patent_doc_number] => 20040247681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Drug release system for controlled therapy'
[patent_app_type] => new
[patent_app_number] => 10/486130
[patent_app_country] => US
[patent_app_date] => 2004-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8177
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20040247681.pdf
[firstpage_image] =>[orig_patent_app_number] => 10486130
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/486130 | Drug release system for controlled therapy | Jul 21, 2004 | Abandoned |
Array
(
[id] => 5732202
[patent_doc_number] => 20060257319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Method for in vivo determination on tested animals of the efficient concentration of deuterium depleted water for cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 10/567842
[patent_app_country] => US
[patent_app_date] => 2004-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3527
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257319.pdf
[firstpage_image] =>[orig_patent_app_number] => 10567842
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/567842 | Method for in vivo determination on tested animals of the efficient concentration of deuterium depleted water for cancer therapy | Jul 19, 2004 | Abandoned |
Array
(
[id] => 7761075
[patent_doc_number] => 08114384
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-14
[patent_title] => 'Process for the production of an abuse-proofed solid dosage form'
[patent_app_type] => utility
[patent_app_number] => 10/890704
[patent_app_country] => US
[patent_app_date] => 2004-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10804
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/114/08114384.pdf
[firstpage_image] =>[orig_patent_app_number] => 10890704
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/890704 | Process for the production of an abuse-proofed solid dosage form | Jul 13, 2004 | Issued |